• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Evaluation and management of pain in autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病的疼痛评估与管理。
Adv Chronic Kidney Dis. 2010 May;17(3):e1-e16. doi: 10.1053/j.ackd.2010.01.005.
2
Autosomal dominant polycystic kidney disease and pain - a review of the disease from aetiology, evaluation, past surgical treatment options to current practice.常染色体显性多囊肾病与疼痛——从病因、评估、既往手术治疗选择到当前实践对该疾病的综述
J Postgrad Med. 2004 Jul-Sep;50(3):222-6.
3
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.建立常染色体显性遗传性多囊肾病的核心结局集：肾脏病预后质量倡议-多囊肾病（SONG-PKD）共识研讨会报告。
Am J Kidney Dis. 2021 Feb;77(2):255-263. doi: 10.1053/j.ajkd.2020.05.024. Epub 2020 Aug 6.
4
Surgical cyst decortication in autosomal dominant polycystic kidney disease.常染色体显性遗传多囊肾病的手术去囊皮治疗。
J Endourol. 2013 May;27(5):528-34. doi: 10.1089/end.2012.0529. Epub 2013 Feb 5.
5
Management of pain in autosomal dominant polycystic kidney disease and anatomy of renal innervation.常染色体显性多囊肾病的疼痛管理与肾神经支配解剖学
J Urol. 2015 May;193(5):1470-8. doi: 10.1016/j.juro.2014.10.124. Epub 2014 Dec 19.
6
Laparoscopic renal denervation and nephropexy for autosomal dominant polycystic kidney disease related pain in adolescents.腹腔镜肾去神经术和肾固定术治疗青少年常染色体显性多囊肾病相关疼痛
J Urol. 2006 Jun;175(6):2274-6; discussion 2276. doi: 10.1016/S0022-5347(06)00336-3.
7
Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease.腹腔镜下囊肿去顶术对常染色体显性多囊肾病患者肾功能、高血压和疼痛控制的长期影响。
J Urol. 2012 Oct;188(4):1239-44. doi: 10.1016/j.juro.2012.06.026. Epub 2012 Aug 16.
8
A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.常染色体显性多囊肾病慢性疼痛有效管理的逐步方法。
Nephrol Dial Transplant. 2014 Sep;29 Suppl 4(Suppl 4):iv142-53. doi: 10.1093/ndt/gfu073.
9
Autosomal dominant polycystic kidney disease: pathophysiology and treatment.常染色体显性多囊肾病：病理生理学与治疗
ANNA J. 1997 Feb;24(1):45-51; quiz 52-3.
10
Pain in renal disease.
J Pain Palliat Care Pharmacother. 2014 Dec;28(4):409-11. doi: 10.3109/15360288.2014.972007. Epub 2014 Oct 28.

引用本文的文献

1
Empowering women at the heart of autosomal dominant polycystic kidney disease: Addressing unique challenges gender-sensitive approach.以常染色体显性多囊肾病为核心赋予女性力量：采用对性别敏感的方法应对独特挑战。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251345944. doi: 10.1177/17455057251345944. Epub 2025 Jul 19.
2
Changes in Protein Expression of Renal Drug Transporters and Drug-Metabolizing Enzymes in Autosomal Dominant Polycystic Kidney Disease Patients.常染色体显性多囊肾病患者肾脏药物转运体和药物代谢酶蛋白表达的变化
Clin Pharmacol Ther. 2025 Sep;118(3):682-692. doi: 10.1002/cpt.3715. Epub 2025 May 15.
3
Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD).肾病的药物治疗：从一般指导到针对特定患者亚组的具体建议——常染色体显性多囊肾病（ADPKD）的故事。
Expert Opin Drug Metab Toxicol. 2025 Jun;21(6):677-687. doi: 10.1080/17425255.2025.2501127. Epub 2025 May 7.
4
Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances.常染色体显性多囊肾病：近期遗传学和临床进展概述
Ren Fail. 2025 Dec;47(1):2492374. doi: 10.1080/0886022X.2025.2492374. Epub 2025 Apr 23.
5
Effectiveness of abdominal bracing core exercises as rehabilitation therapy for reducing abdominal symptoms in patients with autosomal dominant polycystic kidney disease and significant polycystic liver disease.腹部支撑核心训练作为康复治疗手段对常染色体显性多囊肾病合并显著多囊肝病患者减轻腹部症状的有效性。
Ren Fail. 2025 Dec;47(1):2457519. doi: 10.1080/0886022X.2025.2457519. Epub 2025 Mar 11.
6
Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病疾病进展的决定因素
J Pers Med. 2024 Sep 2;14(9):936. doi: 10.3390/jpm14090936.
7
Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.常染色体显性多囊肾病中的疼痛与健康相关生活质量：一项全国患者驱动注册研究的结果
Kidney Med. 2024 Mar 24;6(5):100813. doi: 10.1016/j.xkme.2024.100813. eCollection 2024 May.
8
A Step Ahead toward Measuring Pain in Autosomal Dominant Polycystic Kidney Disease (ADPKD).迈向测量常染色体显性多囊肾病（ADPKD）疼痛的新一步。
Clin J Am Soc Nephrol. 2023 Feb 1;18(2):160-162. doi: 10.2215/CJN.0000000000000042. Epub 2023 Jan 17.
9
Polycystic Kidney Disease Drug Development: A Conference Report.多囊肾病药物研发：会议报告
Kidney Med. 2022 Dec 27;5(3):100596. doi: 10.1016/j.xkme.2022.100596. eCollection 2023 Mar.
10
A Systematic Review of Reported Outcomes in ADPKD Studies.常染色体显性多囊肾病（ADPKD）研究中报告结果的系统评价
Kidney Int Rep. 2022 Jul 5;7(9):1964-1979. doi: 10.1016/j.ekir.2022.06.012. eCollection 2022 Sep.

本文引用的文献

1
The HALT polycystic kidney disease trials: design and implementation.HALT 多囊肾病试验：设计与实施。
Clin J Am Soc Nephrol. 2010 Jan;5(1):102-9. doi: 10.2215/CJN.04310709.
2
Diagnosis and localization of infected renal cyst by diffusion-weighted magnetic resonance imaging in polycystic kidney disease.
Int J Urol. 2009 Nov;16(11):918-9. doi: 10.1111/j.1442-2042.2009.02387.x.
3
"An evil heritage": interview study of pain and autosomal dominant polycystic kidney disease.“一种不良遗传因素”：疼痛与常染色体显性多囊肾病的访谈研究
Pain Manag Nurs. 2009 Sep;10(3):134-41. doi: 10.1016/j.pmn.2009.03.002.
4
Cyst ablation using a mixture of N-butyl cyanoacrylate and iodized oil in patients with autosomal dominant polycystic kidney disease: the long-term results.使用氰基丙烯酸正丁酯和碘化油混合物对常染色体显性遗传性多囊肾病患者进行囊肿消融：长期结果
Korean J Radiol. 2009 Jul-Aug;10(4):377-83. doi: 10.3348/kjr.2009.10.4.377. Epub 2009 Jun 25.
5
A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs.长效与短效阿片类药物治疗慢性非癌性疼痛的比较：根据患者需求定制治疗方案。
Mayo Clin Proc. 2009 Jul;84(7):602-12. doi: 10.1016/S0025-6196(11)60749-0.
6
Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation.多囊肝病：肝切除术、囊肿开窗术及肝移植的批判性评估
Ann Surg. 2009 Jul;250(1):112-8. doi: 10.1097/SLA.0b013e3181ad83dc.
7
Cyst infections in patients with autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者的囊肿感染
Clin J Am Soc Nephrol. 2009 Jul;4(7):1183-9. doi: 10.2215/CJN.01870309. Epub 2009 May 21.
8
A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain.一项比较针刺疗法、模拟针刺疗法和慢性下背痛常规护理的随机试验。
Arch Intern Med. 2009 May 11;169(9):858-66. doi: 10.1001/archinternmed.2009.65.
9
Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.常染色体显性多囊肾病患者肾结石的评估
Clin J Am Soc Nephrol. 2009 Apr;4(4):838-44. doi: 10.2215/CJN.03100608. Epub 2009 Apr 1.
10
Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients.经导管动脉栓塞治疗常染色体显性多囊肾病患者的巨大多囊肝
J Korean Med Sci. 2009 Feb;24(1):57-61. doi: 10.3346/jkms.2009.24.1.57. Epub 2009 Feb 28.

常染色体显性遗传性多囊肾病的疼痛评估与管理。

Evaluation and management of pain in autosomal dominant polycystic kidney disease.

机构信息

Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Adv Chronic Kidney Dis. 2010 May;17(3):e1-e16. doi: 10.1053/j.ackd.2010.01.005.

DOI:10.1053/j.ackd.2010.01.005
PMID:20439087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4144785/
Abstract

Transient episodes of pain are common in autosomal dominant polycystic kidney disease (ADPKD). A small fraction of patients have disabling chronic pain. In this review, we discuss the etiologies of pain in ADPKD; review how ADPKD patients should be assessed; and discuss medical, surgical, and other management options.

摘要

常染色体显性多囊肾病（ADPKD）患者常出现短暂性疼痛发作。少数患者存在致残性慢性疼痛。在本篇综述中，我们讨论了 ADPKD 患者疼痛的病因；回顾了 ADPKD 患者的评估方法；并讨论了药物、手术和其他治疗选择。